This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEW YORK (
TheStreet) -- Shares of specialty pharma company
KV Pharmaceutical(KV-A) were zooming over 150% to $3.85 after U.S. regulators approved its drug, Makena, used to reduce the risk of preterm birth in women with a history of going into labor earlier than 37 weeks. Over 11 million shares were changing hands in afternoon trading.
Shares of timeshare operator
Silverleaf(SVLF) soared 70% to $2.44 after hedge fund
Cerberus Capital said it would buy the company for $94 million, a 75% premium to its previous day's closing price.
Opnext(OPXT) saw its share spurt 30% to $2.62 after it said its losses narrowed in the fiscal third quarter and issued an upbeat forecast for the fourth quarter.
Orexigen Therapeutics(OREX - Get Report) were once again attracting buying interest. The stock crashed over 70% earlier this week after regulators rejected its obesity drug. But shares were climbing 17% on Friday to $3.46.
China MediaExpress(CCME) denied a short-seller's allegations of fraud late Thursday. Muddy Waters Research, which has a short position in the stock, had accused the company of
engaging in a massive pump and dump scheme.
Shares were surging Friday by nearly 20% to $13.50 after plunging by 33% on Thursday.
Silicon Image(SIMG) jumped 15% to $8.87 after its results and first quarter forecasts beat estimates.
Cirrus Logic(CRUS) and video services provider
Harmonic(HLIT) were also prominent gainers in the small-cap sector on Friday trading.
-- Written by Shanthi Bharatwaj in New York
>To contact the writer of this article, click here:
>To follow the writer on Twitter, go to
>To submit a news tip, send an email to: